Florida Health Daily
SEE OTHER BRANDS

Your best source on healthcare and wellness news from Florida

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on April 4, 2025

Prizm Medical and Lovell Team Up to Revolutionize Access to Electrotherapy Devices for Veterans and Military Healthcare

Prizm Medical and Lovell Team Up to Revolutionize Access to Electrotherapy Devices for Veterans and Military Healthcare

Prizm Medical and Lovell Join Forces to Enhance Electrotherapy Access for Veterans and Military Healthcare Providers PENSACOLA , FL, UNITED STATES, April 4, 2025 /⁨EINPresswire.com⁩/ -- Lovell® Government Services and Prizm Medical Inc., a leading …

PacBio Grants Equity Incentive Award to New Employee

PacBio Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted a non- …

CodaPet launches compassionate in-home pet euthanasia services in St. Augustine, FL

CodaPet launches compassionate in-home pet euthanasia services in St. Augustine, FL

The veterinarian-owned startup empowers a network of veterinarians who provide in-home euthanasia to ease the passing of pets at home, surrounded by loved ones. ST. AUGUSTINE, FL, UNITED STATES, April 4, 2025 /⁨EINPresswire.com⁩/ -- CodaPet proudly …

AIM ImmunoTech Announces NYSE American Notice of Delisting and Appeal

AIM ImmunoTech Announces NYSE American Notice of Delisting and Appeal

OCALA, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (“AIM” or the “Company”) (NYSE American: AIM), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and …

Alumis and ACELYRIN File Joint Definitive Proxy Statement for Proposed Merger

Alumis and ACELYRIN File Joint Definitive Proxy Statement for Proposed Merger

Stockholders to benefit from differentiated late-stage portfolio of therapies and strong balance sheet Boards unanimously recommend stockholders vote “FOR” the merger Transaction expected to be completed in second quarter of 2025 SOUTH SAN FRANCISCO, Calif …

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, …

Breaking Barriers in Autism: European Wellness Biomedical Group Unveils Bioregenerative Breakthroughs with Prof. Mike Chan

Breaking Barriers in Autism: European Wellness Biomedical Group Unveils Bioregenerative Breakthroughs with Prof. Mike Chan

BAODING, China, April 05, 2025 (GLOBE NEWSWIRE) --  European Wellness Biomedical Group (EWBG), a global pioneer in bioregenerative medicine and wellness innovation, today unveiled new breakthroughs in autism-focused therapies under the leadership of Prof. …

Edesa Biotech Announces Chief Financial Officer Transition

Edesa Biotech Announces Chief Financial Officer Transition

TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced the appointment of Peter J. Weiler …

Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high …

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that on April 1, 2025 the Company granted inducement …

Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum’s Board of Directors granted an inducement award consisting of non-qualified stock options to …

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NAARDEN, the Netherlands and MIAMI, April 04, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients …

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WESTLAKE VILLAGE, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an …

Bioprocess Optimization and Digital Bio-manufacturing Market Forecast 2029

Bioprocess Optimization and Digital Bio-manufacturing Market Forecast 2029

Boston, April 04, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Bioprocess Optimization and Digital Bio-manufacturing: Global Markets” is expected to grow from $24.3 billion in 2024 to $39.6 billion by the end of 2029 at a …

American Nurses Enterprise Names New Chief Nursing Officer

American Nurses Enterprise Names New Chief Nursing Officer

SILVER SPRING, MD, April 04, 2025 (GLOBE NEWSWIRE) -- The American Nurses Enterprise, which includes the American Nurses Association, the American Nurses Credentialing Center, and the American Nurses Foundation, is pleased to announce the appointment of …

Canadian Pet Population Survey Highlights the Importance of Access to Veterinary Care

Canadian Pet Population Survey Highlights the Importance of Access to Veterinary Care

TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- The latest findings from the 2024 Canadian Pet Population Survey reveal significant insights into the pet ownership landscape in Canada. Conducted by Léger, a leading Canadian research and analytics firm, the …

Le sondage sur la population des animaux de compagnie au Canada souligne l’importance de l’accès aux soins vétérinaires

Le sondage sur la population des animaux de compagnie au Canada souligne l’importance de l’accès aux soins vétérinaires

TORONTO, 04 avr. 2025 (GLOBE NEWSWIRE) -- Les derniers résultats du sondage sur la population canadienne des animaux de compagnie 2024 révèlent des informations importantes sur les propriétaires d’animaux de compagnie au Canada. Mené par Léger, une firme …

Bispecific Trispecific Antibodies Market Size FDA  Approval Clinical Trials Drug Sales Insight 2030

Bispecific Trispecific Antibodies Market Size FDA Approval Clinical Trials Drug Sales Insight 2030

Delhi, April 04, 2025 (GLOBE NEWSWIRE) -- Over the last two decades, immunotherapy has transformed treatment strategies across various medical fields. The effectiveness of monoclonal antibodies in specifically targeting certain antigens has led to the …

Energetic Harmony Expands Holistic Stress Relief Services with Emotion Code for Professionals Facing Chronic Stress or Past Trauma

Energetic Harmony Expands Holistic Stress Relief Services with Emotion Code for Professionals Facing Chronic Stress or Past Trauma

TAMPA BAY, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- Energetic Harmony℠, a leader in holistic stress relief, proudly announces the expansion of its services to include Emotion Code—a powerful modality specifically designed to help age 30+ professionals …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service